StartUp Health is investing in a global army of Health Transformers to improve the health and wellbeing of everyone in the world.
For women who have big ideas,
we’re here to help make them happen.
Vivo Capital is a global healthcare investment firm that has been investing for over 20 years. Our investments across multiple funds and strategies are driven by a value and growth-oriented investment strategy, combined with extensive medical and scientific expertise.
Marc Andreessen, famous for proclaiming that software was “eating the world,” said in 2009 that the one place his eponymous Silicon Valley venture capital firm would never invest was health care.
How things have changed.
Arlan Hamilton isn’t afraid to dismantle everything Silicon Valley stands for. As a black, queer woman who skipped college to pursue a career in the music industry, she looks nothing like the white, straight, Stanford-educated bros who dominate venture capital.
And yet, having been homeless and broke just three years ago, Hamilton successfully forced her way into Silicon Valley and founded Backstage Capital, a seed investment fund that backs high-potential, underrepresented, and often underestimated startup founders.
When I made the transition from my first career at Microsoft to my second career in philanthropy, I didn’t think that my success rate would change much. I was now putting money into new ways to reduce poverty and disease. Discovering a new vaccine, I figured, would be just as hard as discovering the next tech unicorn. (Vaccines are much harder, it turns out.)
After 20 years of investing in health, though, one type of investment has surprised me—because, unlike investing in a new vaccine or technology, the success rate is very high. It’s what people in the global-health business call “financing and delivery.” Decades ago, these investments weren’t sure bets, but today, they almost always pay off in a big way.
Steve Case says people outside Silicon Valley feel left out. He has a plan to change that.
Now a counter movement, led by entrepreneurs who are jaded by the traditional playbook, is rejecting that model. While still a small part of the start-up community, these founders have become more vocal in the last year as they connect venture capitalists’ insatiable appetite for growth to the tech industry’s myriad crises.
Shockingly, the healthcare industry hasn’t kept pace with the aging population. Maysam Ghovanloo, a Georgia Tech professor of Electrical and Biomedical Engineering, feels one of the costliest problems facing seniors today is medication compliance.
A lack of personal savings, competition from abroad, and the threat of another economic downturn make it harder for Millennials to thrive as entrepreneurs.
The landscape is changing, slowly but promisingly, for women entrepreneurs. Not only are more women starting businesses, including technology-enabled firms across multiple industries, but female entrepreneurs are gaining ground in running more profitable businesses and delivering higher returns to investors.
Even so, women still raise just 2% of venture capital dollars, and their company valuations remain lower than those run by men.
“In spite of market volatility, the potential curative impact of many of the breakthroughs this year continues to be the driver of long-term value, and of continued venture investment. We are in a revolutionary time in biotech,” ARCH Venture Partners cofounder Bob Nelsen wrote in an email to Forbes.
GV, formerly and popularly known as Google Ventures, has been making a major push into biopharma and life sciences. The venture capital arm of Google holding company Alphabet has investments in many of biopharma’s best known names, including Editas, 23andMe, Grail, and Denali Therapeutics.
Zuckerberg’s ability to remake the world in his own image, in his own lifetime, is unprecedented. Andrew Carnegie opened his first library when he was 68, and only managed to get around $5 billion in today’s dollars out the door before he died.
Oak HC/FT invests in this kind of middle-spectrum venture, ventures that are bold and smart, but also practical with right-now benefits. Here are a couple of examples...
Chamath Palihapitiya shames industry’s shortage of women and minorities; ‘equal-opportunity’ aggressor.
The investors who support emerging medical technologies play an important role in determining which new therapies reach the public.
Why the couple wants to give away $3 billion to “cure all diseases”
What body parts are seeing the most striking rise in venture-capital funding?
The answer in recent years has been the eyes and ears, as investors have poured money into treatments for diseases causing blindness, hearing loss and other diseases affecting an aging population.
Change and variety are part of being human, and so we shouldn’t be surprised that entrepreneurs’ brains are a little bit different.
An app to distinguish reality from hallucination, a probiotic for acne, and a lifesaving pump for heart-failure patients. These are but a few of brilliant ideas from promising healthcare start-ups.
Blueprint Health has the largest network of mentors with healthcare expertise of any accelerator and co-working space. We believe pairing talented entrepreneurs with experienced healthcare entrepreneurs and venture capitalists can provide you with warm introductions and the strategic and tactical advice you need to succeed.
Our mission is to: Provide the next generation of medical entrepreneurs with the insight, network and opportunities to lead innovative improvement in healthcare.
We're powering the future of healthcare. Rock Health funds and supports startups building the next generation of technologies transforming healthcare. Join us and build something useful.
VentureHealth is an investment portal for accredited investors who want access to high growth opportunities in the $2.5 trillion healthcare sector.
Our mission is to dramatically transform clinical outcomes by capitalizing breakthrough innovations.
Honoring world-changing scientists, inspiring a knowledge culture, expanding our understanding of the Universe.
Our goals for the future center on two ideas: advancing human potential and promoting equal opportunity. We want to push the boundaries of how great a human life can be and make sure that everyone has access to these opportunities regardless of their circumstances.
Cigna Ventures is the strategic corporate venture capital partner of choice in the health care industry. We work closely with entrepreneurs to accelerate growth and innovation through strategic use of capital and deep partnerships.
Our unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
We invest in smart people solving difficult problems.
Frazier Healthcare is one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies.
Good Ventures is a philanthropic foundation whose mission is to help humanity thrive.
Launched as Google Ventures in 2009, GV is the venture capital arm of Alphabet, Inc. We’ve invested in more than 300 companies that push the edge of what’s possible. In the fields of life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture, our companies aim to improve lives and change industries.
Health Care Investment Visions is a venture management, funding and governance firm driven by deep industry knowledge and proven management principles.
Healthbox launched in 2010 as one of the world’s first healthcare-focused accelerators. In partnership with leading healthcare organizations, we set out with the goal of supporting entrepreneurial innovation to drive the industry forward.
HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" start ups at the intersection of healthcare with the computer and mobility worlds. HealthTechCapital is creating a new ecosystem with leading edge clinical providers, venture firms and other strategic industry players.
InCube Ventures is a venture firm that invests in and nurtures promising life sciences companies. Our mission is to identify extraordinary innovations that solve unmet clinical needs for large patient populations, and help bring those innovations to market.
We support entrepreneurs who are expanding the possibilities of human life through the creative application of technology. Our portfolio reflects our interest in both fearless solutions to daunting problems and the invention of new consumer experiences. We believe that inevitable ventures emerge at the intersection of the rational and the radical, and we'd love to learn about yours.
Life Science Angels is a not-for-profit corporation created for the benefit of its members. We have established two separate committees to review biotechnology and medical device investment opportunities.
LSAN provides early stage life science companies with the operational support, mentorship and financial and professional network to grow and succeed.
We’re here to build heroic new businesses to improve people’s lives. To inspire change. To embrace experimentation. To do something that matters.
We invest in real software solving real problems.
Healthcare has never been as exciting as it is today. Montreux invests in leading high growth companies that offer the most promising products, technologies, and services.
We are the first national network of angel investors supporting media and tech startups that disrupt politics and catalyze progressive change.
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The firm is dedicated to investing in outstanding biomedical technology and life science companies.
We make invention accessible.
We believe the best ideas in the world aren't actually in the world, they're locked inside people's heads.
We exist to solve that problem.
Revolution invests in people and ideas that can change the world. Our mission is to build disruptive, innovative companies that offer more choice, convenience, and control for both consumers and businesses. We bring a unique approach to investing.
Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling demonstrates that significant companies are best built in close working partnerships with entrepreneurs.
At Social Capital, our mission is to transform society by using technology to solve the world’s hardest problems. We do this by utilizing our people and capital to help bring the most promising and disruptive ideas worldwide for maximum impact.
The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology.
Town Hall Ventures is dedicated to working side-by-side with visionary entrepreneurs who want to transform care delivery and health outcomes for the most underserved and higher need populations across the country. Community by community, town by town.
We envision a world in which science and technology innovators have the support, training, and access to networks and resources they need to solve the world’s most difficult problems.
Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology.
Some companies may need no more than seed funding. Others will go through several rounds. There is no right answer; how much funding you need depends on the kind of company you start.
At Y Combinator, our goal is to get you through the first phase. This usually means: get you to the point where you’ve built something impressive enough to raise money on a larger scale. Then we can introduce you to later stage investors—or occasionally even acquirers.
The platform for startups.
Less than 10% of all venture capital deals go to women, People of Color, and LGBT founders. Other VCs see this as a pipeline problem. We see it as the biggest opportunity in investment.
Our networks and relationships across our hundreds of employees within Bain Capital and our hundreds of portfolio companies throughout the world gives us an unparalleled ability to make potential customer introductions, create partnership opportunities and assist in helping find the right executives to help grow our companies. Let us connect you to the best in your industry.
At Highland we work hard to build value in each of our companies. That value is reflected in our track record, our organizational structure, our team-oriented approach and in the way that we operate every day.
Our business is about helping entrepreneurs the people who change the way we live and work by creating new products and services convert their ideas and ambitions into reality.
For five decades we have partnered with intrepid founders to build iconic companies that made history. Today, Kleiner Perkins continues that legacy, investing in founders with bold ideas that span industries and continents, partnering with them from inception to IPO and beyond to maximize the potential of their ideas… and make history.
The NVCA represents the public policy interests of the venture capital community, strives to maintain high professional standards, provides reliable industry data, sponsors professional development, and facilitates interaction among its members.
We help local, national, and global nonprofits raise funds by providing strategy focused on great impact, creative that brings it to life, and executional support that makes it happen.